Related Experiment Video
Updated: Oct 15, 2026

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
Relation of Helicobacter pylori infection and angiographically demonstrated coronary artery disease
1Department of Internal Medicine, Chi Mei Foundation Hospital, Yung Kang City, Tainan, Taiwan.
Insights
This study investigated the link between Helicobacter pylori (H. pylori) infection and coronary heart disease. Researchers found no significant association between H. pylori seropositivity and increased risk of coronary artery disease.
Area of Science:
- Cardiology
- Infectious Diseases
- Epidemiology
Background:
- Conventional coronary risk factors do not fully explain coronary heart disease (CHD) incidence.
- Helicobacter pylori (H. pylori) genomic material has been detected in coronary arteries of myocardial infarct patients.
- Investigating H. pylori as a potential coronary risk factor is warranted.
Purpose of the Study:
- To determine if H. pylori infection is associated with an increased risk of coronary heart disease.
- To explore the relationship between H. pylori seropositivity and coronary artery lesions.
Main Methods:
- Prospective study of patients undergoing coronary angiography.
- Cases (N=165) had ≥50% coronary artery lesions; controls (N=127) had normal angiography.
- Serum IgG antibodies to H. pylori were measured using ELISA; demographic, cardiovascular risk, and socioeconomic data were collected.
Main Results:
- H. pylori seropositivity was not significantly associated with coronary artery disease (OR 0.66, P=0.12), even after adjustment (OR 0.59, P=0.09).
- No association was found between H. pylori seropositivity and conventional cardiovascular risk factors.
- A trend of higher H. pylori positivity in cases with more severe coronary artery disease was not statistically significant.
Conclusions:
- This study found no increased seropositivity for H. pylori in subjects with coronary artery disease.
- Previous H. pylori infection may not be a significant factor in determining coronary heart disease risk.
- Further research is needed to fully understand the complex interplay between infections and cardiovascular health.
Abstract:
Conventional coronary risk factors explain only part of the variation in the incidence of cases of coronary heart disease. Recently H. pylori genomic material has been demonstrated in the coronary arteries of myocardial infarct. In searching for additional coronary risk factors, the potential role of H. pylori infection deserves to be investigated. To clarify if H. pylori infection is associated with an increased risk of coronary heart disease, a series of patients admitted to the Cardiac Catheterization Laboratory for coronary angiography were recruited prospectively. Cases (N = 165) were defined as those who had at least one coronary artery lesion occupying at least 50% of the luminal diameter on coronary angiography. Patients who had normal coronary angiography were selected as controls (N = 127). Demographic data, cardiovascular risk factors, and socioeconomic status were measured in both of the patients and controls. Stored serum specimens from both groups were tested for the presence of serum IgG antibody to H. pylori using enzyme-linked immunosorbent assay; 69.1% of the cases and 77.2% of the controls were seropositive for H. pylori (odds ratio 0.66, 95% CI 0.38-1.16, P = 0.12). After adjustment for age, gender, cardiovascular risk factors, and socioeconomic class, this remained nonsignificant (odds ratio 0.59, 95% CI 0.32-1.09, P = 0.09). H. pylori seropositivity was not associated with several coronary risk factors in either cases or controls. The proportion of H. pylori-positive patients was higher among the cases with triple vessel disease (77.5%) than those with double vessel disease (67.3%) and single vessel disease (65.7%); however, the differences were not statistically significant (odds ratio 0.57, 95% CI 0.23-1.4, P = 0.19). In this study no increase was found in H. pylori seropositivity in subjects with coronary artery disease. This minor association suggests that previous H. pylori infection, reflecting the early childhood environment, may not be important in determining the risk of coronary heart disease.
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy